244 related articles for article (PubMed ID: 27777961)
41. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients.
Goldshtein I; Nguyen AM; dePapp AE; Ish-Shalom S; Chandler JM; Chodick G; Shalev V
Arch Osteoporos; 2018 Mar; 13(1):15. PubMed ID: 29502187
[TBL] [Abstract][Full Text] [Related]
42. Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy.
Fixen CW; Fixen DR
Expert Opin Pharmacother; 2017 Dec; 18(18):2001-2006. PubMed ID: 29172834
[TBL] [Abstract][Full Text] [Related]
43. TRPV4 deficiency causes sexual dimorphism in bone metabolism and osteoporotic fracture risk.
van der Eerden BC; Oei L; Roschger P; Fratzl-Zelman N; Hoenderop JG; van Schoor NM; Pettersson-Kymmer U; Schreuders-Koedam M; Uitterlinden AG; Hofman A; Suzuki M; Klaushofer K; Ohlsson C; Lips PJ; Rivadeneira F; Bindels RJ; van Leeuwen JP
Bone; 2013 Dec; 57(2):443-54. PubMed ID: 24084385
[TBL] [Abstract][Full Text] [Related]
44. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Anti-diabetic agents and fracture risk].
Okazaki R
Clin Calcium; 2008 Aug; 18(8):1154-61. PubMed ID: 18677054
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
Raška I; Rašková M; Zikán V; Škrha J
Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review.
Jud P; Sourij H
Diabetes Res Clin Pract; 2019 Feb; 148():54-63. PubMed ID: 30500546
[TBL] [Abstract][Full Text] [Related]
47. [Antidiabetic drugs and their effect on bone].
Jackuliak P; Kužma M; Payer J
Vnitr Lek; 2017; 63(9):609-616. PubMed ID: 29120659
[TBL] [Abstract][Full Text] [Related]
48. The diabetic paradox: Bone mineral density and fracture in type 2 diabetes.
Botella Martínez S; Varo Cenarruzabeitia N; Escalada San Martin J; Calleja Canelas A
Endocrinol Nutr; 2016 Nov; 63(9):495-501. PubMed ID: 27481443
[TBL] [Abstract][Full Text] [Related]
49. Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosis.
Seeliger C; Schyschka L; Kronbach Z; Wottge A; van Griensven M; Wildemann B; Vester H
Eur J Med Res; 2015 Jan; 20(1):1. PubMed ID: 25563300
[TBL] [Abstract][Full Text] [Related]
50. [Bone quality changes in diabetes].
Wada S; Kamiya S; Fukawa T
Clin Calcium; 2008 May; 18(5):600-5. PubMed ID: 18445877
[TBL] [Abstract][Full Text] [Related]
51. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.
Sorocéanu MA; Miao D; Bai XY; Su H; Goltzman D; Karaplis AC
J Endocrinol; 2004 Oct; 183(1):203-16. PubMed ID: 15525588
[TBL] [Abstract][Full Text] [Related]
52. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
53. [Bone diseases caused by impaired glucose and lipid metabolism].
Kanazawa I; Sugimoto T
Clin Calcium; 2013 Nov; 23(11):1605-11. PubMed ID: 24162600
[TBL] [Abstract][Full Text] [Related]
54. Advanced glycation end products play adverse proinflammatory activities in osteoporosis.
Sanguineti R; Puddu A; Mach F; Montecucco F; Viviani GL
Mediators Inflamm; 2014; 2014():975872. PubMed ID: 24771986
[TBL] [Abstract][Full Text] [Related]
55. Fat's loss is bone's gain.
Pei L; Tontonoz P
J Clin Invest; 2004 Mar; 113(6):805-6. PubMed ID: 15067310
[TBL] [Abstract][Full Text] [Related]
56. [Diabetes mellitus and bone].
Kanazawa I; Sugimoto T
Clin Calcium; 2016 Aug; 26(8):1185-93. PubMed ID: 27461503
[TBL] [Abstract][Full Text] [Related]
57. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
[TBL] [Abstract][Full Text] [Related]
58. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
[TBL] [Abstract][Full Text] [Related]
59. A direct role of collagen glycation in bone fracture.
Poundarik AA; Wu PC; Evis Z; Sroga GE; Ural A; Rubin M; Vashishth D
J Mech Behav Biomed Mater; 2015 Dec; 52():120-130. PubMed ID: 26530231
[TBL] [Abstract][Full Text] [Related]
60. Pathogenesis of diabetic nephropathy: a radical approach.
Salahudeen AK; Kanji V; Reckelhoff JF; Schmidt AM
Nephrol Dial Transplant; 1997 Apr; 12(4):664-8. PubMed ID: 9140991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
